Editas Medicine (EDIT) Treasury Shares (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Treasury Shares data on file, last reported at $595730.0 in Q4 2025.

• On a quarterly basis, Treasury Shares fell 74.39% year-over-year to $595730.0 in Q4 2025; TTM through Dec 2025 was $595730.0, a 74.39% decrease from a year earlier, with the FY2025 full-year figure at $595730.0, down 74.39% from the prior year.
• Treasury Shares for Q4 2025 stood at $595730.0, down from $652267.0 in the prior quarter.
• Over the last five years, Treasury Shares for EDIT reached as high as $2.7 million in Q1 2024 and fell as low as $595730.0 in Q4 2025.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.5 million in 2022.
• Across the five-year window, Treasury Shares soared 138.43% in 2022 and sank 74.39% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $628732.0 in 2021, then surged by 138.43% to $1.5 million in 2022, then soared by 40.56% to $2.1 million in 2023, then increased by 10.41% to $2.3 million in 2024, then sank by 74.39% to $595730.0 in 2025.
• Per Business Quant data, the three most recent Treasury Shares figures were $595730.0 in Q4 2025, $652267.0 in Q3 2025, and $923539.0 in Q2 2025.